Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Making the most of evaluation: a mixed methods study in the English NHS.
Salisbury C, Stewart K, Purdy S, Thorp H, Cameron A, Lart R, Peckham S, Calnan M. Salisbury C, et al. Among authors: thorp h. J Health Serv Res Policy. 2011 Oct;16(4):218-25. doi: 10.1258/jhsrp.2011.010137. Epub 2011 Aug 30. J Health Serv Res Policy. 2011. PMID: 21878444
Lessons from evaluation of the NHS white paper Our Health, Our Care, Our Say.
Salisbury C, Stewart K, Purdy S, Thorp H, Cameron A, Lart R, Peckham S, Calnan M. Salisbury C, et al. Among authors: thorp h. Br J Gen Pract. 2011 Nov;61(592):e766-71. doi: 10.3399/bjgp11X606780. Br J Gen Pract. 2011. PMID: 22054342 Free PMC article. No abstract available.
A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial.
Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Searle A, Haase AM, Taylor AH, Fox KR, Baxter H, Davis M, Thorp H, Winder R, Wright C, Calnan M, Lawlor DA, Peters TJ, Sharp DJ, Turner KM, Montgomery AA, Lewis G. Chalder M, et al. Among authors: thorp h. Health Technol Assess. 2012;16(10):1-164, iii-iv. doi: 10.3310/hta16100. Health Technol Assess. 2012. PMID: 22398106 Free article. Clinical Trial.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Munro APS, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, Enever Y, Gokani K, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kwok J, Lambe T, Libri V, Llewelyn MJ, McGregor AC, Minassian AM, Moore P, Mughal M, Mujadidi YF, Murira J, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Salkeld J, Saralaya D, Sharma S, Sheridan R, Sturdy A, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Nguyen-Van-Tam JS, Snape MD, Liu X, Faust SN; COV-BOOST study group. Munro APS, et al. Lancet. 2021 Dec 18;398(10318):2258-2276. doi: 10.1016/S0140-6736(21)02717-3. Epub 2021 Dec 2. Lancet. 2021. PMID: 34863358 Free PMC article. Clinical Trial.
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
Munro APS, Feng S, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, Enever Y, Qureshi E, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kanji N, Libri V, Llewelyn MJ, McGregor AC, Maallah M, Minassian AM, Moore P, Mughal M, Mujadidi YF, Holliday K, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Bawa T, Saralaya D, Sharma S, Sheridan R, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Lambe T, Nguyen-Van-Tam JS, Snape MD, Liu X, Faust SN; COV-BOOST study group. Munro APS, et al. Lancet Infect Dis. 2022 Aug;22(8):1131-1141. doi: 10.1016/S1473-3099(22)00271-7. Epub 2022 May 9. Lancet Infect Dis. 2022. PMID: 35550261 Free PMC article. Clinical Trial.
Tolerance on trial.
Thorp HH. Thorp HH. Science. 2024 Dec 20;386(6728):1325. doi: 10.1126/science.adv2874. Epub 2024 Dec 19. Science. 2024. PMID: 39700276
The great work continues.
Thorp HH. Thorp HH. Science. 2024 Dec 13;386(6727):1193. doi: 10.1126/science.adv1489. Epub 2024 Dec 12. Science. 2024. PMID: 39666786
Editorial Expression of Concern.
Thorp HH. Thorp HH. Science. 2024 Dec 6;386(6726):1102. doi: 10.1126/science.adu7744. Epub 2024 Dec 5. Science. 2024. PMID: 39637007 No abstract available.
Editorial Expression of Concern.
Thorp HH. Thorp HH. Science. 2024 Dec 6;386(6726):1102. doi: 10.1126/science.adu7951. Epub 2024 Dec 5. Science. 2024. PMID: 39637004 No abstract available.
Trust edges up-slightly.
Thorp HH. Thorp HH. Science. 2024 Nov 22;386(6724):831. doi: 10.1126/science.adu7081. Epub 2024 Nov 21. Science. 2024. PMID: 39571010
201 results